| Title |
Natural Products to Counteract the Epidemic of Cardiovascular and Metabolic Disorders
|
|---|---|
| Published in |
Molecules, June 2016
|
| DOI | 10.3390/molecules21060807 |
| Pubmed ID | |
| Authors |
Birgit Waltenberger, Andrei Mocan, Karel Šmejkal, Elke H. Heiss, Atanas G. Atanasov |
| Abstract |
Natural products have always been exploited to promote health and served as a valuable source for the discovery of new drugs. In this review, the great potential of natural compounds and medicinal plants for the treatment or prevention of cardiovascular and metabolic disorders, global health problems with rising prevalence, is addressed. Special emphasis is laid on natural products for which efficacy and safety have already been proven and which are in clinical trials, as well as on plants used in traditional medicine. Potential benefits from certain dietary habits and dietary constituents, as well as common molecular targets of natural products, are also briefly discussed. A glimpse at the history of statins and biguanides, two prominent representatives of natural products (or their derivatives) in the fight against metabolic disease, is also included. The present review aims to serve as an "opening" of this special issue of Molecules, presenting key historical developments, recent advances, and future perspectives outlining the potential of natural products for prevention or therapy of cardiovascular and metabolic disease. |
X Demographics
The data shown below were collected from the profiles of 474 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 59 | 12% |
| India | 29 | 6% |
| United Kingdom | 15 | 3% |
| Mexico | 12 | 3% |
| Canada | 9 | 2% |
| France | 6 | 1% |
| Venezuela, Bolivarian Republic of | 6 | 1% |
| Brazil | 5 | 1% |
| Australia | 4 | <1% |
| Other | 72 | 15% |
| Unknown | 257 | 54% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 397 | 84% |
| Scientists | 38 | 8% |
| Practitioners (doctors, other healthcare professionals) | 25 | 5% |
| Science communicators (journalists, bloggers, editors) | 12 | 3% |
| Unknown | 2 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 196 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Indonesia | 1 | <1% |
| Mexico | 1 | <1% |
| United States | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 192 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 26 | 13% |
| Student > Ph. D. Student | 22 | 11% |
| Researcher | 18 | 9% |
| Student > Master | 12 | 6% |
| Student > Postgraduate | 11 | 6% |
| Other | 44 | 22% |
| Unknown | 63 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 30 | 15% |
| Agricultural and Biological Sciences | 19 | 10% |
| Biochemistry, Genetics and Molecular Biology | 19 | 10% |
| Chemistry | 18 | 9% |
| Medicine and Dentistry | 16 | 8% |
| Other | 21 | 11% |
| Unknown | 73 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 388. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 April 2021.
All research outputs
#80,437
of 25,743,152 outputs
Outputs from Molecules
#24
of 24,038 outputs
Outputs of similar age
#1,677
of 369,852 outputs
Outputs of similar age from Molecules
#3
of 288 outputs
Altmetric has tracked 25,743,152 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 24,038 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 369,852 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 288 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.